Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-133373

Chief Executive Officer sold 15,000 shares at $55.10 ($826,565)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2024-12-02 Sale 10b5-1 −15,000 $55.10 $826,565 181,540 D
Open-market sales · 15,000 sh · avg $55.10 · $826,565
Loading xslF345X05/ownership.xml…